Results 131 to 140 of about 12,266 (204)

Molecular mechanisms underlying the erectogenic effects of nutraceutical lunamarine, a novel PDE5 inhibitor derived from watermelon (Citrullus lanatus)

Discover Food
The research paper investigates the phytochemicals of watermelon (Citrullus lanatus) as potential novel inhibitors of phosphodiesterase type 5 (PDE5), which is essential for treating erectile dysfunction and pulmonary arterial hypertension.
Oluwaseun E. Agboola, Zainab A. Ayinla, Samuel S. Agboola, Theophilus A. Adegbuyi, Janet F. Akinseye, A. Sijuade, Adebimpe H. Egbebi, Olutosin S. Ilesanmi, Adebanke A. Agboola, Oluwatobi K. Ibrahim   +9 more
doaj   +1 more source

Sexual dysfunction in cardiovascular disease [PDF]

, 2011
Aitchison, M., Connelly, D.T., Mair, F.S., Morrison, D.   +3 more
core   +1 more source

Repurposing PDE5-Inhibitors: Sildenafil Drives Arteriogenesis via Localized Regenerative Inflammation. [PDF]

Int J Mol Sci
Elbs K, Bobrowski L, Arnholdt C, Kübler M, Götz P, Rohrmoser MR, Merkus D, Lasch M, Deindl E.   +8 more
europepmc   +1 more source

PDE5 inhibitors: looking beyond ED.

International journal of clinical practice, 2003
openaire   +3 more sources

The impact of PDE5 inhibitors on cardiovascular outcomes. [PDF]

Glob Cardiol Sci Pract
Ghantous I, Tlais M, Khatib AE, Ghantous G, Maroun G, Challita A, Ayek M, Barmo G, Sahyoun M, El Kari G.   +9 more
europepmc   +1 more source

Cyclic Nucleotide Phosphodiesterase Families as Targets to Treat Pulmonary Arterial Hypertension: Beyond PDE5 Inhibitors? [PDF]

Cells
Wang L, Fischmeister R, Manoury B.
europepmc   +1 more source

Analysis of Phosphodiesterase-5 (PDE5) Inhibitors in Modulating Inflammatory Markers in Humans: A Systematic Review and Meta-Analysis. [PDF]

Int J Mol Sci
Cianciarulo C, Nguyen TH, Zacharias A, Standen N, Tucci J, Irving H.   +5 more
europepmc   +1 more source

Vardenafil - PDE5 inhibitor number 3

International Journal of Clinical Practice, 2004
openaire   +1 more source

An overview on pharmaceutical applications of phosphodiesterase enzyme 5 (PDE5) inhibitors. [PDF]

Mol Divers
Nemr MTM, Abdelaziz MA, Teleb M, Elmasry AE, Elshaier YAAM.   +4 more
europepmc   +1 more source

Rational Design and Optimization of Novel PDE5 Inhibitors for Targeted Colorectal Cancer Therapy: An In Silico Approach. [PDF]

Int J Mol Sci
Oladeji SM, Conteh DN, Bello LA, Adegboyega AE, Shokunbi OS.   +4 more
europepmc   +1 more source